2740495-53-6

2740495-53-6 structure

Name: c-Met/HDAC-IN-2
Chemical Name: c-Met/HDAC-IN-2
CAS Number: 2740495-53-6
Molecular Formula: C₃₄H₃₃N₅O₇
Molecular Weight: 623.66
Catalog: Signaling Pathways Apoptosis Apoptosis
Create Date: 2022-07-02 19:52:56
Modify Date: 2024-01-05 20:36:47
c-Met/HDAC-IN-2 is a highly potent c-Met and HDAC dual inhibitor with IC50s of 18.49 nM and 5.40 nM for HDAC1 and c-Met, respectively. c-Met/HDAC-IN-2 has antiproliferative activities against certain cancer cell lines. c-Met/HDAC-IN-2 can cause G2/M-phase arrest and induce apoptosis in HCT-116. c-Met/HDAC-IN-2 can be used for researching anti-cancer resistance[1].

Name	c-Met/HDAC-IN-2

Description	c-Met/HDAC-IN-2 is a highly potent c-Met and HDAC dual inhibitor with IC50s of 18.49 nM and 5.40 nM for HDAC1 and c-Met, respectively. c-Met/HDAC-IN-2 has antiproliferative activities against certain cancer cell lines. c-Met/HDAC-IN-2 can cause G2/M-phase arrest and induce apoptosis in HCT-116. c-Met/HDAC-IN-2 can be used for researching anti-cancer resistance[1].
Related Catalog	Signaling Pathways >> Apoptosis >> Apoptosis Research Areas >> Cancer Signaling Pathways >> Cell Cycle/DNA Damage >> HDAC Signaling Pathways >> Epigenetics >> HDAC Signaling Pathways >> Protein Tyrosine Kinase/RTK >> c-Met/HGFR
Target	HDAC1:18.49 nM (IC50) c-Met:5.4 nM (IC50)
In Vitro	c-Met/HDAC-IN-2 (compound 14X) (0-20 μM; 72 hours) exhibits antiproliferative activities against HCT-116, MCF-7 and A549[1]. c-Met/HDAC-IN-2 (0.2-5 μM; 48 hours) induces of cancer cell apoptosis in a dose-dependent manner[1]. c-Met/HDAC-IN-2 (0.2-5 μM; 48 hours) significantly causes G2/M-phase arrest in HCT-116 cells in a dose dependent manner[1]. Cell Proliferation Assay Cell Line: HCT-116, MCF-7 and A549[1] Concentration: 0-20 μM Incubation Time: 72 hours Result: Exhibited antiproliferative activities against HCT-116, MCF-7 and A549 with IC50s of 0.22 ± 0.09 μM, 1.59 ± 0.06 μM and 0.22 ± 0.04 μM, respectively. Apoptosis Analysis Cell Line: HTC-116[1] Concentration: 0.2, 1 and 5 μM Incubation Time: 48 hours Result: The percentage of apoptotic cells was 4.19%, 11.53% and 21.48% at 0.2 μM, 1.0 μM and 5.0 μM, respectively. Cell Cycle Analysis Cell Line: HTC-116[1] Concentration: 0.2, 1 and 5 μM Incubation Time: 48 hours Result: Significantly caused G2/M-phase arrest in HCT-116 cells in a dose dependent manner.
References	[1]. Hu H, Chen F, Dong Y, et al. Discovery of Novel c-Mesenchymal-Epithelia transition factor and histone deacetylase dual inhibitors. Eur J Med Chem. 2020;204:112651.

Molecular Formula	C₃₄H₃₃N₅O₇
Molecular Weight	623.66

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

2740495-53-6	2439175-23-0
1635406-73-3	2443380-34-3
2415291-03-9	2426675-70-7
1446324-05-5	2760326-29-0
2377724-93-9	2084836-84-8
2229547-21-9	2228825-92-9
2228697-53-6	2227719-87-9
2229238-95-1	2228404-63-3
2228839-16-3	2228386-40-9
2229239-07-8	2385187-34-6